陕西医学杂志Issue(3)：311-312,2.DOI:10.3969/j.issn.1000-7377.2015.03.018
淋巴瘤化疗后侵袭性肺部真菌感染26例临床分析
Lymphoma after chemotherapy for 26 cases of invasive pulmonary fungal infection in clinical analysis
摘要
Abstract
S Objective :The present study mainly discusses and analyzes the clinical characteristics of in‐vasive pulmonary fungal infections (IPFI) in patients with lymphoma who receiving chemotherapy .Methods :We analyzed 26 patients with lymphoma combining IPFI after receiving chemotherapy .Results :①The rate of diagnosis of IPFI in patients with the non‐Hodgkin′s lymphoma and Hodgkin′s disease was 1 .6% and 3 .3% ,respectively ,in the five years .There was no significantly difference among ages and sexes .IPFI‐attributable mortality rate was higher in HSCT patients than those in receiving chemotherapy alone .② The infection of Candida albicans was also the majority of the fungus infection .③The rate of diagnosis arises ,with the suspected rate of diagnosis decreasing .④Among the four kinds of antifungal drugs ,the curative effect of Voriconazole was the best .Conclusion :Candida albicans is lymphoma after chemotherapy for invasive pulmonary fungal infection of the main pathogenic bacteria of voriconazole in the treatment of its significant effect .关键词
淋巴瘤/肺病/药物相关副作用及不良反应/细菌感染和真菌病/白色念珠菌Key words
Lymphoma Lung diseases/Drug-related side effects and adverse reactions/Bacterial inte-ctions and mycoses/Candida albicans分类
医药卫生引用本文复制引用
谢伟成..淋巴瘤化疗后侵袭性肺部真菌感染26例临床分析[J].陕西医学杂志,2015,(3):311-312,2.基金项目
广东省卫生厅科技计划项目 （）
